Company Filing History:
Years Active: 2005
Title: **Richard F. Barbas: Innovator in Ophthalmic Device Manufacturing**
Introduction
Richard F. Barbas is a distinguished inventor based in Jacksonville, FL, known for his contributions to the field of ophthalmic devices. He holds one patent that showcases his innovative approach to enhancing the manufacturing process of these vital medical instruments.
Latest Patents
Richard F. Barbas is credited with a single patent titled "Method and mold for making ophthalmic devices." This significant invention outlines a process and structure for improving the release of molded ophthalmic devices from their molds. The patent describes a method involving a mold with two halves, each featuring opposing surfaces, including a hollowed-out cavity to form the ophthalmic device. A unique aspect of this patent includes the design of a release element with a ramped surface that facilitates the efficient ejection of the finished product from the mold.
Career Highlights
Richard is currently employed at Johnson & Johnson Vision Care, Inc., where he leverages his expertise in design and production. His work in this world-renowned company demonstrates his commitment to advancing technologies that improve patient care and medical outcomes in the field of vision correction.
Collaborations
Throughout his career, Richard has worked closely with other professionals in the field, notably Scott Frederick Ansell and Michael William Litwin. These collaborations highlight the importance of teamwork in driving innovation and generating successful patents in the highly specialized domain of ophthalmic technologies.
Conclusion
In conclusion, Richard F. Barbas's contributions to the field of ophthalmic device manufacturing demonstrate the critical role of inventors in shaping the future of healthcare. His innovative patent not only improves the manufacturing process but also underscores his dedication to enhancing the quality of medical devices. As technology continues to evolve, the work of inventors like Richard will remain at the forefront of advancements in the medical field.